once-weekly semaglutide in adults with overweight or obesity Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss early trials. The potential benefit Semaglutide for weight loss -

ReadyRx injectable glutathione (administered intramuscularly or subcutaneously) offers several advantages over traditional IV glutathione infusions including convenience of home administration versus required clinic visits, substantially lower cost per treatment, flexibility of administration timing to suit individual schedules, and comparable bioavailability and therapeutic efficacy to IV administration for most applications

Fibra de Achicoria ( Cichorium intybus L.): fibra natural de origen vegetal

They are a true Partner on our projects

Most patients notice their first changes in appetite and food preferences within 37 days of starting injections, but the timeline to meaningful weight loss varies based on starting dose, individual metabolism, and adherence to lifestyle changes

Wegovy is more effective in clinical trials, showing greater average weight loss than Contrave

BPC-157 is a synthetic peptide fragment